ROSILAND BUCK: Open Payments
NPI 1578782819 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,705 in 66 payments from 15 companies in 2025. Trend: 2023 $2,044 · 2024 $1,751 · 2025 $1,705
Food & beverage: $1,697Education: $9
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 30 | $842 |
| Janssen Biotech, Inc. | 6 | $244 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $152 |
| PFIZER INC. | 5 | $112 |
| Myriad Genetic Laboratories, Inc. | 3 | $55 |
| UROGEN PHARMA, INC. | 2 | $55 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Endo USA, Inc. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
Products named: PROVENGE, RYBREVANT, Nubeqa, XTANDI, ERLEADA, PROLARIS, JELMYTO, GEMTESA.
Industry payments across NC — which companies pay providers there.
